Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2022-2028


Jan, 2023 | Report ID: 246132 | 165 | Pharmaceuticals and Healthcare

As the global economy mends, the 2021 growth of Nausea And Vomiting Treatment will have significant change from previous year. According to our latest study, the global Nausea And Vomiting Treatment market size is USD million in 2022 from USD 5082.5 million in 2021, with a change of % between 2021 and 2022. The global Nausea And Vomiting Treatment market size will reach USD 8025.1 million in 2028, growing at a CAGR of 6.7% over the analysis period.

The United States Nausea And Vomiting Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nausea And Vomiting Treatment market, reaching US$ million by the year 2028. As for the Europe Nausea And Vomiting Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Nausea And Vomiting Treatment players cover Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), and Kyowa Kirin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Serotonin Receptor Antagonist

Neurokinin NK1 Receptor Antagonist

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

CINV

PONV

Motion Sickness

Pregnancy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Merck & Co. Inc.

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd.

Taiji group

Novartis

Heron Therapeutics

Atnahs Pharma UK Limited

Mylan

Duchesnay

Tesaro


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nausea And Vomiting Treatment Market Size 2017-2028

2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Nausea And Vomiting Treatment Segment by Type

2.2.1 Serotonin Receptor Antagonist

2.2.2 Neurokinin NK1 Receptor Antagonist

2.2.3 Others

2.3 Nausea And Vomiting Treatment Market Size by Type

2.3.1 Nausea And Vomiting Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

2.4 Nausea And Vomiting Treatment Segment by Application

2.4.1 CINV

2.4.2 PONV

2.4.3 Motion Sickness

2.4.4 Pregnancy

2.4.5 Others

2.5 Nausea And Vomiting Treatment Market Size by Application

2.5.1 Nausea And Vomiting Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

3 Nausea And Vomiting Treatment Market Size by Player

3.1 Nausea And Vomiting Treatment Market Size Market Share by Players

3.1.1 Global Nausea And Vomiting Treatment Revenue by Players (2020-2022)

3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Nausea And Vomiting Treatment by Regions

4.1 Nausea And Vomiting Treatment Market Size by Regions (2017-2022)

4.2 Americas Nausea And Vomiting Treatment Market Size Growth (2017-2022)

4.3 APAC Nausea And Vomiting Treatment Market Size Growth (2017-2022)

4.4 Europe Nausea And Vomiting Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2017-2022)

5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2017-2022)

5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2017-2022)

6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2017-2022)

6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Nausea And Vomiting Treatment by Country (2017-2022)

7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022)

7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2017-2022)

8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Nausea And Vomiting Treatment Market Forecast

10.1 Global Nausea And Vomiting Treatment Forecast by Regions (2023-2028)

10.1.1 Global Nausea And Vomiting Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Nausea And Vomiting Treatment Forecast

10.1.3 APAC Nausea And Vomiting Treatment Forecast

10.1.4 Europe Nausea And Vomiting Treatment Forecast

10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast

10.2 Americas Nausea And Vomiting Treatment Forecast by Country (2023-2028)

10.2.1 United States Nausea And Vomiting Treatment Market Forecast

10.2.2 Canada Nausea And Vomiting Treatment Market Forecast

10.2.3 Mexico Nausea And Vomiting Treatment Market Forecast

10.2.4 Brazil Nausea And Vomiting Treatment Market Forecast

10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2023-2028)

10.3.1 China Nausea And Vomiting Treatment Market Forecast

10.3.2 Japan Nausea And Vomiting Treatment Market Forecast

10.3.3 Korea Nausea And Vomiting Treatment Market Forecast

10.3.4 Southeast Asia Nausea And Vomiting Treatment Market Forecast

10.3.5 India Nausea And Vomiting Treatment Market Forecast

10.3.6 Australia Nausea And Vomiting Treatment Market Forecast

10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2023-2028)

10.4.1 Germany Nausea And Vomiting Treatment Market Forecast

10.4.2 France Nausea And Vomiting Treatment Market Forecast

10.4.3 UK Nausea And Vomiting Treatment Market Forecast

10.4.4 Italy Nausea And Vomiting Treatment Market Forecast

10.4.5 Russia Nausea And Vomiting Treatment Market Forecast

10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Nausea And Vomiting Treatment Market Forecast

10.5.2 South Africa Nausea And Vomiting Treatment Market Forecast

10.5.3 Israel Nausea And Vomiting Treatment Market Forecast

10.5.4 Turkey Nausea And Vomiting Treatment Market Forecast

10.5.5 GCC Countries Nausea And Vomiting Treatment Market Forecast

10.6 Global Nausea And Vomiting Treatment Forecast by Type (2023-2028)

10.7 Global Nausea And Vomiting Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Merck & Co. Inc.

11.1.1 Merck & Co. Inc. Company Information

11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered

11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Merck & Co. Inc. Main Business Overview

11.1.5 Merck & Co. Inc. Latest Developments

11.2 Helsinn Group

11.2.1 Helsinn Group Company Information

11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered

11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Helsinn Group Main Business Overview

11.2.5 Helsinn Group Latest Developments

11.3 Unimed Pharmaceuticals (AbbVie Inc.)

11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information

11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered

11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview

11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments

11.4 Kyowa Kirin

11.4.1 Kyowa Kirin Company Information

11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered

11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Kyowa Kirin Main Business Overview

11.4.5 Kyowa Kirin Latest Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered

11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sanofi Main Business Overview

11.5.5 Sanofi Latest Developments

11.6 Qilu Pharma

11.6.1 Qilu Pharma Company Information

11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered

11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Qilu Pharma Main Business Overview

11.6.5 Qilu Pharma Latest Developments

11.7 Teva Pharmaceutical Industries Ltd.

11.7.1 Teva Pharmaceutical Industries Ltd. Company Information

11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered

11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments

11.8 Taiji group

11.8.1 Taiji group Company Information

11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered

11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Taiji group Main Business Overview

11.8.5 Taiji group Latest Developments

11.9 Novartis

11.9.1 Novartis Company Information

11.9.2 Novartis Nausea And Vomiting Treatment Product Offered

11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Novartis Main Business Overview

11.9.5 Novartis Latest Developments

11.10 Heron Therapeutics

11.10.1 Heron Therapeutics Company Information

11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered

11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Heron Therapeutics Main Business Overview

11.10.5 Heron Therapeutics Latest Developments

11. Atnahs Pharma UK Limited

11.11.1 Atnahs Pharma UK Limited Company Information

11.11.2 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered

11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Atnahs Pharma UK Limited Main Business Overview

11.11.5 Atnahs Pharma UK Limited Latest Developments

11.12 Mylan

11.12.1 Mylan Company Information

11.12.2 Mylan Nausea And Vomiting Treatment Product Offered

11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Mylan Main Business Overview

11.12.5 Mylan Latest Developments

11.13 Duchesnay

11.13.1 Duchesnay Company Information

11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered

11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Duchesnay Main Business Overview

11.13.5 Duchesnay Latest Developments

11.14 Tesaro

11.14.1 Tesaro Company Information

11.14.2 Tesaro Nausea And Vomiting Treatment Product Offered

11.14.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Tesaro Main Business Overview

11.14.5 Tesaro Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Nausea And Vomiting Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Serotonin Receptor Antagonist

Table 3. Major Players of Neurokinin NK1 Receptor Antagonist

Table 4. Major Players of Others

Table 5. Nausea And Vomiting Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

Table 8. Nausea And Vomiting Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

Table 11. Global Nausea And Vomiting Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Nausea And Vomiting Treatment Revenue Market Share by Player (2020-2022)

Table 13. Nausea And Vomiting Treatment Key Players Head office and Products Offered

Table 14. Nausea And Vomiting Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Nausea And Vomiting Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2017-2022)

Table 19. Americas Nausea And Vomiting Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Nausea And Vomiting Treatment Market Size Market Share by Country (2017-2022)

Table 21. Americas Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

Table 23. Americas Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

Table 25. APAC Nausea And Vomiting Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Nausea And Vomiting Treatment Market Size Market Share by Region (2017-2022)

Table 27. APAC Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

Table 29. APAC Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

Table 31. Europe Nausea And Vomiting Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Nausea And Vomiting Treatment Market Size Market Share by Country (2017-2022)

Table 33. Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

Table 35. Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Nausea And Vomiting Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Nausea And Vomiting Treatment

Table 44. Key Market Challenges & Risks of Nausea And Vomiting Treatment

Table 45. Key Industry Trends of Nausea And Vomiting Treatment

Table 46. Global Nausea And Vomiting Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Nausea And Vomiting Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Nausea And Vomiting Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 52. Merck & Co. Inc. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 53. Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered

Table 54. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Merck & Co. Inc. Main Business

Table 56. Merck & Co. Inc. Latest Developments

Table 57. Helsinn Group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 58. Helsinn Group Nausea And Vomiting Treatment Product Offered

Table 59. Helsinn Group Main Business

Table 60. Helsinn Group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Helsinn Group Latest Developments

Table 62. Unimed Pharmaceuticals (AbbVie Inc.) Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 63. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered

Table 64. Unimed Pharmaceuticals (AbbVie Inc.) Main Business

Table 65. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments

Table 67. Kyowa Kirin Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 68. Kyowa Kirin Nausea And Vomiting Treatment Product Offered

Table 69. Kyowa Kirin Main Business

Table 70. Kyowa Kirin Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Kyowa Kirin Latest Developments

Table 72. Sanofi Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 73. Sanofi Nausea And Vomiting Treatment Product Offered

Table 74. Sanofi Main Business

Table 75. Sanofi Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Sanofi Latest Developments

Table 77. Qilu Pharma Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 78. Qilu Pharma Nausea And Vomiting Treatment Product Offered

Table 79. Qilu Pharma Main Business

Table 80. Qilu Pharma Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Qilu Pharma Latest Developments

Table 82. Teva Pharmaceutical Industries Ltd. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 83. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered

Table 84. Teva Pharmaceutical Industries Ltd. Main Business

Table 85. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 87. Taiji group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 88. Taiji group Nausea And Vomiting Treatment Product Offered

Table 89. Taiji group Main Business

Table 90. Taiji group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Taiji group Latest Developments

Table 92. Novartis Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 93. Novartis Nausea And Vomiting Treatment Product Offered

Table 94. Novartis Main Business

Table 95. Novartis Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Novartis Latest Developments

Table 97. Heron Therapeutics Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 98. Heron Therapeutics Nausea And Vomiting Treatment Product Offered

Table 99. Heron Therapeutics Main Business

Table 100. Heron Therapeutics Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Heron Therapeutics Latest Developments

Table 102. Atnahs Pharma UK Limited Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 103. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered

Table 104. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Atnahs Pharma UK Limited Main Business

Table 106. Atnahs Pharma UK Limited Latest Developments

Table 107. Mylan Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 108. Mylan Nausea And Vomiting Treatment Product Offered

Table 109. Mylan Main Business

Table 110. Mylan Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Mylan Latest Developments

Table 112. Duchesnay Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 113. Duchesnay Nausea And Vomiting Treatment Product Offered

Table 114. Duchesnay Main Business

Table 115. Duchesnay Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Duchesnay Latest Developments

Table 117. Tesaro Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors

Table 118. Tesaro Nausea And Vomiting Treatment Product Offered

Table 119. Tesaro Main Business

Table 120. Tesaro Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Tesaro Latest Developments

List of Figures

Figure 1. Nausea And Vomiting Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Nausea And Vomiting Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Nausea And Vomiting Treatment Market Size Market Share by Type in 2021

Figure 7. Nausea And Vomiting Treatment in CINV

Figure 8. Global Nausea And Vomiting Treatment Market: CINV (2017-2022) & ($ Millions)

Figure 9. Nausea And Vomiting Treatment in PONV

Figure 10. Global Nausea And Vomiting Treatment Market: PONV (2017-2022) & ($ Millions)

Figure 11. Nausea And Vomiting Treatment in Motion Sickness

Figure 12. Global Nausea And Vomiting Treatment Market: Motion Sickness (2017-2022) & ($ Millions)

Figure 13. Nausea And Vomiting Treatment in Pregnancy

Figure 14. Global Nausea And Vomiting Treatment Market: Pregnancy (2017-2022) & ($ Millions)

Figure 15. Nausea And Vomiting Treatment in Others

Figure 16. Global Nausea And Vomiting Treatment Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Nausea And Vomiting Treatment Market Size Market Share by Application in 2021

Figure 18. Global Nausea And Vomiting Treatment Revenue Market Share by Player in 2021

Figure 19. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)

Figure 21. APAC Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)

Figure 22. Europe Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)

Figure 24. Americas Nausea And Vomiting Treatment Value Market Share by Country in 2021

Figure 25. Americas Nausea And Vomiting Treatment Consumption Market Share by Type in 2021

Figure 26. Americas Nausea And Vomiting Treatment Market Size Market Share by Application in 2021

Figure 27. United States Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Nausea And Vomiting Treatment Market Size Market Share by Region in 2021

Figure 32. APAC Nausea And Vomiting Treatment Market Size Market Share by Application in 2021

Figure 33. China Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Nausea And Vomiting Treatment Market Size Market Share by Country in 2021

Figure 40. Europe Nausea And Vomiting Treatment Market Size Market Share by Type in 2021

Figure 41. Europe Nausea And Vomiting Treatment Market Size Market Share by Application in 2021

Figure 42. Germany Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application in 2021

Figure 50. Egypt Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 56. APAC Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Europe Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 59. United States Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Canada Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 63. China Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Japan Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Korea Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 67. India Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Australia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Germany Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 70. France Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 71. UK Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Italy Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Russia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Spain Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 77. Israel Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)

Sample Request is not available